Cancer Gene Therapy Market – Forecasts and Opportunity Assessment by Technavio – Business Wire (press release)
Business Wire (press release) |
Cancer Gene Therapy Market – Forecasts and Opportunity Assessment by Technavio
Business Wire (press release) This research report titled ‘Global Cancer Gene Therapy Market 2017-2021′ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for … Global Cancer Gene Therapy Market to Grow at a CAGR of 20.6% by 2021: Favorable Government Regulations for …PR Newswire (press release) Cancer Gene Therapy 2017 Global Market Expected to Grow at CAGR 20.63% and Forecast to 2021Medgadget (blog) |
|
Monsanto, ToolGen announce licensing agreement for CRISPR
Feedstuffs Monsanto Company and ToolGen Inc., a biotechnology company specializing in genome editing, announced this week that the companies have reached a global licensing agreement for the use of ToolGen’s CRISPR technology platform to develop … |
|
Monsanto Licenses ToolGen CRISPR Technology
GenomeWeb NEW YORK (GenomeWeb) – Monsanto announced today that it has licensed a CRISPR technology platform from Korean biotechnology company ToolGen with the intention of developing agricultural products. The global license provides Monsanto with … Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of …GlobeNewswire (press release) |
Medscape |
Immunotherapy in Cancer: Hits and Misses, but Charging Ahead
Medscape After the many success of immunotherapy in various cancer types over the last few years, recent news of failures has come as a bit of a shock. It was a bad day for AstraZeneca in July when stock shares plummeted by more than 16% —the highly … |